Showing 1 - 8 results of 8 for search 'Chen CC', query time: 0.08s Refine Results
  1. 1
    Quantified Facial Rejuvenation Utilizing High Intense Focus Ultrasound with Multiple Penetrative Depths

    Quantified Facial Rejuvenation Utilizing High Intense Focus Ultrasound with Multiple Penetrative Depths by Lio ML, Chang CC, Chuang ADC, Tsai LC, Chen CC

    Published 2022
    Connect to this object online.
    Book
    Save to List
    Saved in:
  2. 2
    Low-density lipoprotein cholesterol outcomes post-non-PCSK9i lipid-lowering therapies in atherosclerotic cardiovascular disease and probable heterozygous familial hypercholesterolemia patients

    Low-density lipoprotein cholesterol outcomes post-non-PCSK9i lipid-lowering therapies in atherosclerotic cardiovascular disease and probable heterozygous familial hypercholesterole... by Chen CC, Rane PB, Hines DM, Patel J, Harrison DJ, Wade RL

    Published 2018
    Connect to this object online.
    Book
    Save to List
    Saved in:
  3. 3
    Improving anticancer efficacy of (-)-epigallocatechin-3-gallate gold nanoparticles in murine B16F10 melanoma cells

    Improving anticancer efficacy of (-)-epigallocatechin-3-gallate gold nanoparticles in murine B16F10 melanoma cells by Chen CC, Hsieh DS, Huang KJ, Chan YL, Hong PD, Yeh MK, Wu CJ

    Published 2014
    Connect to this object online.
    Book
    Save to List
    Saved in:
  4. 4
    Clinical and economic outcomes of a "high-touch" clinical management program for intravenous immunoglobulin therapy

    Clinical and economic outcomes of a "high-touch" clinical management program for intravenous immunoglobulin therapy by Zhu J, Kirkham HS, Ayer G, Chen CC, Wade RL, Karkare SU, Robson CH, Orange JS

    Published 2017
    Connect to this object online.
    Book
    Save to List
    Saved in:
  5. 5
    Demographic And Clinical Characteristics Of Patients Prescribed Proprotein Convertase Subtilisin/kexin Type 9 Inhibitor Therapy And Patients Whose Current Lipid-Lowering Therapy Was Modified

    Demographic And Clinical Characteristics Of Patients Prescribed Proprotein Convertase Subtilisin/kexin Type 9 Inhibitor Therapy And Patients Whose Current Lipid-Lowering Therapy Wa... by Baum SJ, Wade RL, Xiang P, Arellano J, Cerezo Olmos C, Nunna S, Chen CC, Carter CM, Desai NR

    Published 2019
    Connect to this object online.
    Book
    Save to List
    Saved in:
  6. 6
    In silico-based identification of human α-enolase inhibitors to block cancer cell growth metabolically

    In silico-based identification of human α-enolase inhibitors to block cancer cell growth metabolically by Lung J, Chen KL, Hung CH, Chen CC, Hung MS, Lin YC, Wu CY, Lee KD, Shih NY, Tsai YH

    Published 2017
    Connect to this object online.
    Book
    Save to List
    Saved in:
  7. 7
    The Association Between Caustic Ingestion and Psychiatric Comorbidity Based on 396 Adults Within 20 Years

    The Association Between Caustic Ingestion and Psychiatric Comorbidity Based on 396 Adults Within 20 Years by Chen YJ, Seak CJ, Chen CC, Chen TH, Kang SC, Ng CJ, Lee CW, Su MY, Huang HC, Ooyang CH, Hsieh SY, Cheng HT

    Published 2020
    Connect to this object online.
    Book
    Save to List
    Saved in:
  8. 8
    Safety, Tolerability, and Pharmacokinetics of Benralizumab: A Phase 1, Randomized, Single-Blind Study of Healthy Chinese Participants

    Safety, Tolerability, and Pharmacokinetics of Benralizumab: A Phase 1, Randomized, Single-Blind Study of Healthy Chinese Participants by Cheung TT, Mai TH, Chia YL, Yap DYH, Lee CH, Chen CC, Huang Y, Jin Y, Johnston J, Werkström V, Yao Y, Ge X, Zheng W

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:

Search Tools: